C-Mer Medical Holdings 3309.HK · HKD

Its shares trade on HKEX under the ticker 3309.HK. It has been listed since 15 January 2018. In the fiscal year to 31 December 2025, it reported revenue of HK$1.95bn and net income of HK$100.4m. At that date it held total assets of HK$2.73bn and shareholders' equity of HK$1.77bn.

C-MER Eye Care Holdings Ltd. engages in the provision of treatments and therapy services for ophthalmic diseases. The company employs 2,221 full-time employees The company went IPO on 2018-01-15. The firm is engaged in the provision of ophthalmic services; sales of vision aid products including glasses and lens; provision of other medical services including dental, oncology, medical aesthetics, and laboratory services; sales of pharmaceutical products.

Figures and description from our data supplier, not checked against the company's own report.

• Dr. Shun Chiu LamExecutive Chairman of the Board, Chief Executive OfficerHK$6.0m
• Dr. Pak-Kuen AuyeungNon-Executive Independent Chairman of the BoardHK$663,000
• Mr. Wa Ping ChanChief Financial Officer, Company Secretary
• Dr. Yau Wing LeeExecutive Director, Head of Hong Kong OperationHK$240,000
• Ms. Xiaoting LiChief Executive Officer, Executive Vice Chairman of the Board, since 2017HK$3.8m
• Ms. Man Yi SiuChief Operation Officer, Hong Kong
• Mr. Shu Kwan IpNon-Executive Independent DirectorHK$240,000
• Mr. Chiu Cheung MaNon-Executive Independent DirectorHK$240,000
• Mr. Ke YinNon-Executive Independent DirectorHK$240,000

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.